Oric Pharmaceuticals Inc
ORIC11.180USD
-0.260-2.27%
收盘 07/28, 16:00（美东）报价延迟15分钟
794.66M总市值
亏损市盈率 TTM
关于 Oric Pharmaceuticals Inc 公司
ORIC Pharmaceuticals, Inc. 是一家临床阶段的生物制药公司，致力于通过克服癌症耐药性来改善患者的生活。该公司正在开发一系列临床和发现阶段的疗法，旨在通过利用其在三个特定领域的专业知识来对抗癌症的耐药机制：激素依赖性癌症、精准肿瘤学和关键肿瘤依赖性。其临床阶段候选产品包括 ORIC-114，一种脑渗透抑制剂，旨在选择性靶向 EGFR 和 HER2，对外显子 20 插入突变具有高效力，正在针对多种基因定义的癌症进行开发；ORIC-944，一种通过 EED 亚基的多梳抑制复合物 2 (PRC2) 的变构抑制剂，正在为前列腺癌开发；以及 ORIC-533，一种口服生物可利用的小分子 CD73 抑制剂，CD73 是腺苷通路中的一个关键节点，被认为在化疗和免疫疗法治疗方案的耐药性中起着核心作用。
公司简介
公司代码ORIC
公司名称Oric Pharmaceuticals Inc
上市日期Apr 24, 2020
成立日期2014
CEODr. Jacob M. Chacko, M.D.
员工数量115
证券类型Ordinary Share
年结日Apr 24
公司地址240 E. Grand Ave
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94080
电话16503885600
网址https://oricpharma.com/
公司代码ORIC
上市日期Apr 24, 2020
成立日期2014
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jacob M. Chacko, M.D.
Dr. Jacob M. Chacko, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
778.65K
+1.01%
Dr. Richard A. (Rich) Heyman, Ph.D.
Dr. Richard A. (Rich) Heyman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
228.77K
--
Mr. Dominic G. Piscitelli, CPA
Mr. Dominic G. Piscitelli, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik S. Multani, M.D.
Dr. Pratik S. Multani, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Mardi C. Dier
Ms. Mardi C. Dier
Independent Director
Independent Director
--
--
Mr. Steven L. (Steve) Hoerter
Mr. Steven L. (Steve) Hoerter
Independent Director
Independent Director
--
--
Dr. Lori A. Kunkel, M.D.
Dr. Lori A. Kunkel, M.D.
Independent Director
Independent Director
--
--
Dr. Angie J. You, Ph.D.
Dr. Angie J. You, Ph.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Jacob M. Chacko, M.D.
Dr. Jacob M. Chacko, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
778.65K
+1.01%
Dr. Richard A. (Rich) Heyman, Ph.D.
Dr. Richard A. (Rich) Heyman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
228.77K
--
Mr. Dominic G. Piscitelli, CPA
Mr. Dominic G. Piscitelli, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Pratik S. Multani, M.D.
Dr. Pratik S. Multani, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Mardi C. Dier
Ms. Mardi C. Dier
Independent Director
Independent Director
--
--
Mr. Steven L. (Steve) Hoerter
Mr. Steven L. (Steve) Hoerter
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月7日 周六
更新时间: 6月7日 周六
持股股东
股东类型
持股股东
持股股东
占比
VR Adviser, LLC
7.74%
Viking Global Investors LP
7.71%
Pfizer Inc
6.31%
Nextech Invest, Ltd.
6.20%
SR One Capital Management, LP
5.42%
Other
66.62%
持股股东
持股股东
占比
VR Adviser, LLC
7.74%
Viking Global Investors LP
7.71%
Pfizer Inc
6.31%
Nextech Invest, Ltd.
6.20%
SR One Capital Management, LP
5.42%
Other
66.62%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
29.75%
Investment Advisor
25.29%
Venture Capital
22.35%
Hedge Fund
18.29%
Corporation
6.31%
Private Equity
2.48%
Individual Investor
1.63%
Sovereign Wealth Fund
1.56%
Research Firm
0.91%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
285
93.32M
109.50%
+12.16M
2025Q1
294
83.96M
99.59%
+456.78K
2024Q4
284
80.39M
113.18%
-3.73M
2024Q3
272
78.70M
112.04%
-2.29M
2024Q2
265
76.25M
113.03%
-1.57M
2024Q1
276
71.21M
105.62%
-1.02M
2023Q4
259
57.91M
108.09%
+1.21M
2023Q3
260
55.20M
103.62%
-1.09M
2023Q2
255
52.76M
117.11%
+8.95M
2023Q1
257
40.28M
89.44%
-3.51M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
VR Adviser, LLC
6.60M
7.74%
+3.41M
+107.28%
Apr 08, 2025
Viking Global Investors LP
6.57M
7.71%
+2.14M
+48.33%
Mar 31, 2025
Pfizer Inc
5.38M
6.31%
--
--
Mar 31, 2025
Nextech Invest, Ltd.
5.29M
6.2%
--
--
Mar 31, 2025
SR One Capital Management, LP
4.62M
5.42%
+4.62M
--
May 29, 2025
BlackRock Institutional Trust Company, N.A.
4.40M
5.16%
+59.93K
+1.38%
Mar 31, 2025
The Column Group LP
3.54M
4.15%
--
--
Mar 31, 2025
EcoR1 Capital, LLC
3.42M
4.01%
--
--
Mar 31, 2025
Alkeon Capital Management LLC
3.34M
3.92%
+86.63K
+2.66%
Mar 31, 2025
The Vanguard Group, Inc.
3.21M
3.76%
+12.10K
+0.38%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
0.98%
iShares Genomics Immunology and Healthcare ETF
0.92%
SPDR S&P Biotech ETF
0.11%
iShares Micro-Cap ETF
0.11%
iShares Health Innovation Active ETF
0.11%
Direxion Daily S&P Biotech Bull 3X Shares
0.09%
ProShares Ultra Nasdaq Biotechnology
0.08%
Invesco Nasdaq Biotechnology ETF
0.06%
Fidelity Enhanced Small Cap ETF
0.05%
iShares Biotechnology ETF
0.04%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比0.98%
iShares Genomics Immunology and Healthcare ETF
占比0.92%
SPDR S&P Biotech ETF
占比0.11%
iShares Micro-Cap ETF
占比0.11%
iShares Health Innovation Active ETF
占比0.11%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.09%
ProShares Ultra Nasdaq Biotechnology
占比0.08%
Invesco Nasdaq Biotechnology ETF
占比0.06%
Fidelity Enhanced Small Cap ETF
占比0.05%
iShares Biotechnology ETF
占比0.04%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
